1/10
Looks like no tags are added yet.
What tyoe of neuron does AD damage? What are the causes?
Basal forebrain cholinergic neurons.
Protein aggregation (Amyloid and Tau)
Cellular stress (ROS and mitochondria)
Inflammation (glial cells and astrocytes)
What is Lecanemab?
Synthetic antibody that targets Amyloid beta proteins and plaques, helping immune system destroy them. Boston lab
What is Tau and how does it cause AD?
Tau is a protein that stabilizes microtubules.
Amyloid beta causes it to become hyperphosphorylated (Intracellular neurofibrillary tangles), and this disrupts microtubules (transport, communication, synapse formation)
Muscarinic Acetylcholine receptors location and function
M1-Postsynaptic in Hippocampus/cortex. Activation stimulates alpha-secretase.
M2-Presynaptic in basal forebrain cholinergic synapses. Alzheimers results in loss.
Nicotinic acetylcholine receptors function and location
alpha7- high affinity for AB42, disrupts calcium signaling, promotes tau hyperphosphorylation
Alpha4beta2- found around the cortex and hippocampus, lost as cholinergic projections degenerate
N-Methyl-D-Aspartate receptor and Memantine relation to AD
High ambient glutamate overstimulates NMDA receptors, allowing constant Ca influx leading to Tau Phos and apoptosis.
Memantine is a noncompetitive NMDA receptor antagonist, lowering the Ca influx without disrupting function
Neurotrophin receptors names and functions
TrkA- high affinity for Nerve Growth Factor, downregulation leads to trophic atrophy of basal forebrain cholinergic cells
p75(NTR)- mediates pro-apoptotic signals, degenerates neuronal processes
Function of APP
Single pass transmembrane protein involved in synaptic plasticity and cell adhesion
Genetic mutations for AD, early an late onset
Early onset- APP, PSEN1, PSEN2. Altered gamma secretase processing.
Late onset- APOEe4. Reduces AB clearance.
What is the 3XTgAD model and mutations?
A mouse model involving all aspects of AD.
APPswe- increases beta secretase activity
PSEN1m146V- increases AB42
MAPTp301L- promotes hyperphosphorylation of Tau
Walsh et al. paper general purpose
Prove that AB oligomers (small specifically) reduce LTP in vivo (mouse hippocampus). AB antibodies (R1282) and gamma secretase inhibitors (DAPM) prevent this.